Patent · US Active

Modulators

US12371488B2 · kind B2 · utility

0Cited by
86References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 13, 2022
Grant dateJul 29, 2025
Priority date—
Expiry dateApr 13, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that modulate insulin receptor signaling are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.